Michael Nathan VanSaun

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Bailey A. Bye · 6 shared papers, 2022–2025 · strength 1.21
   • Paper Combined Omipalisib and MAPK Inhibition Suppress PDAC Growth. DOI 10.3390/cancers17071152↗
   • Paper Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancr… DOI 10.1136/jitc-2024-010057↗
   • Paper DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells. DOI 10.1038/s41598-025-12967-8↗
2. R. McKinnon Walsh · 5 shared papers, 2022–2025 · strength 1.03
   • Paper Combined Omipalisib and MAPK Inhibition Suppress PDAC Growth. DOI 10.3390/cancers17071152↗
   • Paper Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancr… DOI 10.1136/jitc-2024-010057↗
   • Paper DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells. DOI 10.1038/s41598-025-12967-8↗
3. Appolinaire A. Olou · 5 shared papers, 2022–2025 · strength 0.98
   • Paper Combined Omipalisib and MAPK Inhibition Suppress PDAC Growth. DOI 10.3390/cancers17071152↗
   • Paper Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancr… DOI 10.1136/jitc-2024-010057↗
   • Paper SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1. DOI 10.1007/s12079-022-00691-1↗
4. Mariana T. Ruckert · 5 shared papers, 2022–2025 · strength 0.94
   • Paper Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancr… DOI 10.1136/jitc-2024-010057↗
   • Paper DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells. DOI 10.1038/s41598-025-12967-8↗
   • Paper SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1. DOI 10.1007/s12079-022-00691-1↗
5. Nipun B. Merchant · 7 shared papers, 2018–2025 · strength 0.90
   • Paper Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreat… DOI 10.1158/0008-5472.can-25-1304↗
   • Paper CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Al… DOI 10.1016/j.jcmgh.2025.101606↗
   • Paper Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-19-1043↗
6. Nagaraj S. Nagathihalli · 7 shared papers, 2018–2025 · strength 0.90
   • Paper Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreat… DOI 10.1158/0008-5472.can-25-1304↗
   • Paper CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Al… DOI 10.1016/j.jcmgh.2025.101606↗
   • Paper Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-19-1043↗
7. Jason A. Castellanos · 6 shared papers, 2018–2025 · strength 0.70
   • Paper Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreat… DOI 10.1158/0008-5472.can-25-1304↗
   • Paper Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-19-1043↗
   • Paper Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells. DOI 10.18632/oncotarget.26621↗
8. Austin R. Dosch · 5 shared papers, 2018–2025 · strength 0.57
   • Paper CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Al… DOI 10.1016/j.jcmgh.2025.101606↗
   • Paper Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-19-1043↗
   • Paper Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells. DOI 10.18632/oncotarget.26621↗
9. Chanjuan Shi · 4 shared papers, 2018–2025 · strength 0.50
   • Paper Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreat… DOI 10.1158/0008-5472.can-25-1304↗
   • Paper Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells. DOI 10.18632/oncotarget.26621↗
   • Paper Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer. DOI 10.1158/0008-5472.can-18-0634↗
10. Supriya Srinivasan · 4 shared papers, 2018–2025 · strength 0.47
    • Paper CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Al… DOI 10.1016/j.jcmgh.2025.101606↗
    • Paper Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-19-1043↗
    • Paper Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer. DOI 10.1158/1535-7163.mct-18-0464↗
11. Shrikant Anant · 3 shared papers, 2022–2023 · strength 0.45
    • Paper Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextri… DOI 10.3390/ijms24076336↗
    • Paper Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04572-8↗
    • Paper Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04615-0↗
12. Tulasigeri M. Totiger · 3 shared papers, 2018–2025 · strength 0.35
    • Paper CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Al… DOI 10.1016/j.jcmgh.2025.101606↗
    • Paper Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer. DOI 10.1158/1535-7163.mct-18-0464↗
    • Paper Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer. DOI 10.1158/0008-5472.can-18-0579↗
13. Prasad R. Dandawate · 2 shared papers, 2023 · strength 0.35
    • Paper SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1. DOI 10.1007/s12079-022-00691-1↗
    • Paper Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextri… DOI 10.3390/ijms24076336↗
14. Siddharth Mehra · 2 shared papers, 2021–2025 · strength 0.32
    • Paper CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Al… DOI 10.1016/j.jcmgh.2025.101606↗
    • Paper Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1535-7163.mct-19-1043↗
15. Sharon Manley · 2 shared papers, 2022 · strength 0.29
    • Paper Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04572-8↗
    • Paper Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells. DOI 10.1038/s41419-022-04615-0↗
16. Xi Chen · 1 shared paper, 2025 · strength 0.25
    • Paper Editor's Note: Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreat… DOI 10.1158/0008-5472.can-25-1304↗
17. Emily L. Lasse Opsahl · 1 shared paper, 2025 · strength 0.23
    • Paper DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells. DOI 10.1038/s41598-025-12967-8↗
18. Marina Pasca di Magliano · 1 shared paper, 2025 · strength 0.23
    • Paper DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells. DOI 10.1038/s41598-025-12967-8↗
19. Jiaqi Shi · 1 shared paper, 2025 · strength 0.23
    • Paper DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells. DOI 10.1038/s41598-025-12967-8↗
20. Vanessa S. Silveira · 1 shared paper, 2025 · strength 0.23
    • Paper DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells. DOI 10.1038/s41598-025-12967-8↗
21. Costas Andreas Lyssiotis · 1 shared paper, 2025 · strength 0.23
    • Paper DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells. DOI 10.1038/s41598-025-12967-8↗
22. Filip Bednar · 1 shared paper, 2025 · strength 0.23
    • Paper DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells. DOI 10.1038/s41598-025-12967-8↗
23. Anna Bianchi · 1 shared paper, 2025 · strength 0.20
    • Paper CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Al… DOI 10.1016/j.jcmgh.2025.101606↗
24. Iago De Castro Silva · 1 shared paper, 2025 · strength 0.20
    • Paper CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Al… DOI 10.1016/j.jcmgh.2025.101606↗
25. Jashodeep Datta · 1 shared paper, 2025 · strength 0.20
    • Paper CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Al… DOI 10.1016/j.jcmgh.2025.101606↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.